ABT vs COIN · P/E 25, rev $44.33B vs P/E 64, rev $2.63B
Abbott Laboratories (ABT) versus Coinbase Global Inc (COIN) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported COIN revenue for 2026-06-30 was $2.63B. Net income was -$753.6M. Revenue was up 86.3% from 2026-03-31 to 2026-06-30. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
Not investment advice. Open the ABT and COIN stock pages for the full models.
Not investment advice.